Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Pancreatic Neoplasms"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 39578
Tytuł:
Recent Developments in the Treatment of Pancreatic Cancer.
Autorzy:
Paulino J; General Surgery Department. Hospital da Luz. Lisboa. Portugal.
Mansinho H; Oncology Department. Hospital Garcia de Orta. Almada. Portugal.
Pokaż więcej
Źródło:
Acta medica portuguesa [Acta Med Port] 2023 Oct 02; Vol. 36 (10), pp. 670-678. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pancreatic Neoplasms*/surgery
Carcinoma, Pancreatic Ductal*/surgery
Carcinoma, Pancreatic Ductal*/drug therapy
Humans ; Neoadjuvant Therapy ; Europe
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
Risks and impacts of thromboembolism in patients with pancreatic cancer.
Autorzy:
Chan LL; Sir Yue-kong Pao Centre for Cancer, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Lam KY; Department of Medicine, United Christian Hospital, Hong Kong SAR, China.
Lam DCM; Sir Yue-kong Pao Centre for Cancer, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Lau YM; Sir Yue-kong Pao Centre for Cancer, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Li L; Sir Yue-kong Pao Centre for Cancer, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ng KKC; Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
Tang RSY; Institute of Digestive Disease, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
Chan SL; Sir Yue-kong Pao Centre for Cancer, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Pokaż więcej
Źródło:
Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2023 Oct; Vol. 29 (5), pp. 396-403. Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:
Journal Article
MeSH Terms:
Thromboembolism*/epidemiology
Thromboembolism*/etiology
Thromboembolism*/diagnosis
Pancreatic Neoplasms*/complications
Pancreatic Neoplasms*/epidemiology
Humans ; Retrospective Studies ; Risk Factors
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients.
Autorzy:
Choi W; Center for Clinical Trials, National Cancer Center, Goyang, Korea.; Division of Cancer Biology, Cancer Molecular Biology Branch, Research Institute of National Cancer Center, Goyang, Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
Kim YH; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.; Division of Technology Convergence, Cancer Molecular Imaging Branch, Research Institute of National Cancer Center, Goyang, Korea.
Woo SM; Division of Rare and Refractory Cancer, Immuno-oncology Branch, Research Institute of National Cancer Center, Goyang, Korea.; Center for Liver and Pancreatobiliary Cancer, Hospital, National Cancer Center, Goyang, Korea.
Yu Y; Division of Rare and Refractory Cancer, Targeted Therapy Branch of Research Institute, National Cancer Center, Goyang, Korea.
Lee MR; Division of Technology Convergence, Cancer Molecular Imaging Branch, Research Institute of National Cancer Center, Goyang, Korea.
Lee WJ; Center for Liver and Pancreatobiliary Cancer, Hospital, National Cancer Center, Goyang, Korea.; Division of Clinical Research, Cancer Outcome & Quality Improvement Branch, Research Institute of National Cancer Center, Goyang, Korea.
Chun JW; Center for Liver and Pancreatobiliary Cancer, Hospital, National Cancer Center, Goyang, Korea.; Division of Clinical Research, Interventional Medicine Branch, Research Institute of National Cancer Center, Goyang, Korea.
Sim SH; Center for Breast Cancer, National Cancer Center, Goyang, Korea.; Division of Rare and Refractory Cancer, Anticancer Resistance Branch, Research Institute of National Cancer Center, Goyang, Korea.
Chae H; Center for Breast Cancer, National Cancer Center, Goyang, Korea.; Center for Cancer Data Center, National Cancer Control Institute of National Cancer Center, Goyang, Korea.
Shim H; Department of Laboratory Medicine, National Cancer Center, Goyang, Korea.
Lee KS; Center for Clinical Trials, National Cancer Center, Goyang, Korea.; Center for Breast Cancer, National Cancer Center, Goyang, Korea.
Kong SY; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.; Division of Rare and Refractory Cancer, Targeted Therapy Branch of Research Institute, National Cancer Center, Goyang, Korea.; Department of Laboratory Medicine, National Cancer Center, Goyang, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1077-1086. Date of Electronic Publication: 2023 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/pathology
Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Peritoneal Neoplasms*/pathology
Humans ; Female ; Ascites ; Precision Medicine ; Organoids/pathology
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan.
Autorzy:
Ei S; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Takahashi S; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Ogasawara T; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Mashiko T; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Masuoka Y; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Nakagohri T; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2023 Sep 15; Vol. 17 (5), pp. 698-710. Date of Electronic Publication: 2023 Feb 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/surgery
Carcinoma, Pancreatic Ductal*/surgery
Humans ; Neoadjuvant Therapy ; Japan ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Pancreatectomy
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
Autorzy:
Xun J; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Ohtsuka H; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan. .
Hirose K; Department of Investigative Pathology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Douchi D; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Nakayama S; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Ishida M; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Miura T; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Ariake K; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Mizuma M; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Nakagawa K; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Morikawa T; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Furukawa T; Department of Investigative Pathology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Unno M; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Sep 06; Vol. 23 (1), pp. 835. Date of Electronic Publication: 2023 Sep 06.
Typ publikacji:
Journal Article
MeSH Terms:
Ataxia Telangiectasia*
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Humans ; Gemcitabine ; Drug Resistance, Neoplasm/genetics
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN).
Autorzy:
Brugel M; Université de Reims Champagne-Ardenne, Department of Digestive Oncology, CHU Reims, Reims, France. Electronic address: .
Marulier T; Université de Reims Champagne-Ardenne, Department of Digestive Oncology, CHU Reims, Reims, France.
Evrard C; Department of Medical Oncology, Poitiers University Hospital, Poitiers, France.
Carlier C; Université de Reims Champagne-Ardenne, Department of Digestive Oncology, CHU Reims, Reims, France; Department of Medical Oncology, Godinot Cancer Institute, Reims, France.
Tougeron D; Department of Hepato-Gastro-enterology, Poitiers University Hospital, Poitiers, France.
Piessen G; Department of Digestive and Oncological Surgery, CHRU Lille, CANTHER Laboratory Inserm UMR-S1277, University of Lille, Lille, France.
Truant S; Department of Digestive Surgery and Liver Transplantation Department, CHRU Lille, CANTHER Laboratory Inserm UMR-S1277, University of Lille, Lille, France.
Turpin A; Department of Medical Oncology, CHU Lille, University of Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020 - UMR-S 1277, Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
Williet N; Department of Hepatogastroenterology, CHU Saint Etienne, Saint-Priest-en-Jarez, France.
Botsen D; Université de Reims Champagne-Ardenne, Department of Digestive Oncology, CHU Reims, Reims, France; Department of Medical Oncology, Godinot Cancer Institute, Reims, France.
Brasseur M; Université de Reims Champagne-Ardenne, Department of Digestive Oncology, CHU Reims, Reims, France.
Perrier M; Université de Reims Champagne-Ardenne, Department of Digestive Oncology, CHU Reims, Reims, France.
Bouché O; Université de Reims Champagne-Ardenne, Department of Digestive Oncology, CHU Reims, Reims, France.
Pokaż więcej
Źródło:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2023 Sep; Vol. 23 (6), pp. 622-629. Date of Electronic Publication: 2023 Jun 19.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma*/therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/therapy
Humans ; Genetic Counseling ; Genetic Testing ; Genetic Predisposition to Disease ; Cohort Studies ; Referral and Consultation
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
Pancreatic ductal adenocarcinoma (PDAC) regional nodal disease at standard lymphadenectomy: is MRI accurate for identifying node-positive patients?
Autorzy:
Adham S; Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, 711 Concession Street, Hamilton, ON, L8V 1C3, Canada.; Department of Radiology, McMaster University, Hamilton, ON, Canada.
Ferri M; Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, 711 Concession Street, Hamilton, ON, L8V 1C3, Canada.; Department of Radiology, McMaster University, Hamilton, ON, Canada.
Lee SY; Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, 711 Concession Street, Hamilton, ON, L8V 1C3, Canada.; Department of Radiology, McMaster University, Hamilton, ON, Canada.
Larocque N; Department of Radiology, McMaster University, Hamilton, ON, Canada.; Hamilton General Hospital, Hamilton Health Sciences, Hamilton, ON, Canada.
Alwahbi OA; Department of Radiology, McMaster University, Hamilton, ON, Canada.
Ruo L; Department of Radiology, McMaster University, Hamilton, ON, Canada.; Department of Surgery, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada.
van der Pol CB; Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, 711 Concession Street, Hamilton, ON, L8V 1C3, Canada. .; Department of Radiology, McMaster University, Hamilton, ON, Canada. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Sep; Vol. 33 (9), pp. 5976-5983. Date of Electronic Publication: 2023 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/surgery
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Carcinoma, Pancreatic Ductal*/surgery
Adult ; Humans ; Retrospective Studies ; Lymph Node Excision ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Magnetic Resonance Imaging
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
Autorzy:
Yoon AR; Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Republic of Korea; Institute of Nano Science and Technology (INST), Hanyang University, Seoul, Republic of Korea; Hanyang Institute of Bioscience and Biotechnology (HY-IBB), Hanyang University, Seoul, Republic of Korea.
Hong J; GeneMedicine Co., Ltd., 222 Wangsimni-ro, Seongdong-gu, Seoul, Republic of Korea.
Jung BK; GeneMedicine Co., Ltd., 222 Wangsimni-ro, Seongdong-gu, Seoul, Republic of Korea.
Ahn HM; GeneMedicine Co., Ltd., 222 Wangsimni-ro, Seongdong-gu, Seoul, Republic of Korea.
Zhang S; Department of Medical Oncology, Yanbian University Hospital, Jilin, China.
Yun CO; Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Republic of Korea; Institute of Nano Science and Technology (INST), Hanyang University, Seoul, Republic of Korea; Hanyang Institute of Bioscience and Biotechnology (HY-IBB), Hanyang University, Seoul, Republic of Korea; GeneMedicine Co., Ltd., 222 Wangsimni-ro, Seongdong-gu, Seoul, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2023 Nov 28; Vol. 579, pp. 216456. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Oncolytic Virotherapy*
Oncolytic Viruses*/genetics
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/therapy
Pancreatic Neoplasms*/pathology
Humans ; Adenoviridae/genetics ; Cell Line, Tumor ; Tumor Microenvironment
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
POH1 facilitates pancreatic carcinogenesis through MYC-driven acinar-to-ductal metaplasia and is a potential therapeutic target.
Autorzy:
Jing T; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Xu X; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Wu C; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Wei D; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Yuan L; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Huang Y; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Liu Y; Department of Medical Oncology, Fudan University Shanghai Cancer Center, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. Electronic address: .
Wang B; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2023 Nov 28; Vol. 577, pp. 216444. Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Carcinoma, Pancreatic Ductal*/pathology
Humans ; Mice ; Animals ; Pancreas/pathology ; Carcinogenesis/genetics ; Carcinogenesis/pathology ; Metaplasia/pathology
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex.
Autorzy:
Wang S; School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.; Neuromedicine Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, 518053, China.
Chen J; Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
Li P; Department of Thyroid & Breast Surgery, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China.
Chen Y; School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong. .; Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, 518087, China. .
Pokaż więcej
Źródło:
Cell death & disease [Cell Death Dis] 2023 Nov 25; Vol. 14 (11), pp. 767. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Ferroptosis*/genetics
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
RNA, Long Noncoding*/genetics
Humans ; Cell Line, Tumor ; Sorafenib/pharmacology ; RNA Stability/genetics ; RNA-Binding Protein FUS/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records.
Autorzy:
Hjaltelin JX; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Novitski SI; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jørgensen IF; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Siggaard T; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Vulpius SA; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Westergaard D; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Johansen JS; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
Chen IM; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
Juhl Jensen L; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Copenhagen University Hospital, Rigshospitalet, Blegdamsvej, Copenhagen, Denmark.
Pokaż więcej
Źródło:
ELife [Elife] 2023 Nov 21; Vol. 12. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/epidemiology
Jaundice*
Humans ; Electronic Health Records ; Retrospective Studies ; Routinely Collected Health Data ; Denmark/epidemiology
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B.
Autorzy:
Malvi P; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Chava S; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Cai G; Department of Pathology, Yale University School of Medicine, New Haven, CT 06510, USA.
Hu K; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Zhu LJ; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Edwards YJK; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Green MR; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Gupta R; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35233, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: .
Wajapeyee N; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35233, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: .
Pokaż więcej
Źródło:
Cell reports. Medicine [Cell Rep Med] 2023 Nov 21; Vol. 4 (11), pp. 101285. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/genetics
Mice ; Animals ; Cell Proliferation ; TOR Serine-Threonine Kinases/pharmacology ; TOR Serine-Threonine Kinases/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Neoplasm Proteins ; Mammals
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
Dual-energy computed tomography-based iodine concentration as a predictor of histopathological response to preoperative chemoradiotherapy for pancreatic cancer.
Autorzy:
Ohira S; Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 537-8567, Japan.; Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Department of Comprehensive Radiation Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Ikawa T; Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 537-8567, Japan.
Kanayama N; Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 537-8567, Japan.
Minamitani M; Department of Comprehensive Radiation Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Kihara S; Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 537-8567, Japan.
Inui S; Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 537-8567, Japan.
Ueda Y; Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 537-8567, Japan.
Miyazaki M; Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 537-8567, Japan.
Yamashita H; Department of Radiology, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Nishio T; Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Koizumi M; Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Nakagawa K; Department of Comprehensive Radiation Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Konishi K; Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 537-8567, Japan.
Pokaż więcej
Źródło:
Journal of radiation research [J Radiat Res] 2023 Nov 21; Vol. 64 (6), pp. 940-947.
Typ publikacji:
Journal Article
MeSH Terms:
Iodine*
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/therapy
Humans ; Retrospective Studies ; Contrast Media ; Tomography, X-Ray Computed/methods ; Chemoradiotherapy/methods
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
A case report of huge pancreas mucinous cystic neoplasm during pregnancy: How doctors think.
Autorzy:
Wang L; Department of Obstetrics and Gynecology, Hangzhou Ninth People's Hospital, Hangzhou, China.
Zhu L
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Nov 17; Vol. 102 (46), pp. e34820.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/surgery
Pancreatic Cyst*
Cystadenoma, Mucinous*/diagnosis
Cystadenoma, Mucinous*/surgery
Humans ; Female ; Pregnancy ; Adult ; Cesarean Section ; Pancreas/pathology ; Magnetic Resonance Imaging
Czasopismo naukowe
Szczegóły
Tytuł:
A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Autorzy:
Alshareefy Y; School of Medicine, Trinity College Dublin, The University of Dublin, Ireland.
Cummins S; School of Medicine, Trinity College Dublin, The University of Dublin, Ireland.
Mazzoleni A; Barts and the London School of Medicine and Dentistry, London, United Kingdom.
Sharma V; School of Medicine, Trinity College Dublin, The University of Dublin, Ireland.
Guggilapu S; House Surgeon, Bangalore Medical College and Research.
Leong AWY; University of Malaysia, Kuala Lumpur, Malaysia.
Wireko AA; Sumy State University, Sumy, Ukraine.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Nov 17; Vol. 102 (46), pp. e36094.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Neuroendocrine Tumors*/diagnosis
Neuroendocrine Tumors*/therapy
Neuroendocrine Tumors*/metabolism
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/therapy
Adenoma, Islet Cell*
Humans ; Phosphatidylinositol 3-Kinases ; Prognosis ; Biomarkers
Czasopismo naukowe
Szczegóły
Tytuł:
Long-term survival after surgical resection for bone metastasis from pancreatic cancer: A case report.
Autorzy:
Hayashi K; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Kitago M; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Abe Y; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Yagi H; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Hasegawa Y; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Hori S; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Tanaka M; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Nakano Y; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Asakura K; Department of Thoracic Surgery, Keio University School of Medicine, Shinjuku, Japan.
Masugi Y; Department of Pathology, Keio University School of Medicine, Shinjukusss, Japan.
Kitagawa Y; Department of Surgery, Keio University School of Medicine, Shinjuku, Japan.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Nov 17; Vol. 102 (46), pp. e35856.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Pancreatic Neoplasms*/surgery
Pancreatic Neoplasms*/pathology
Bone Neoplasms*/surgery
Female ; Humans ; Middle Aged ; Pancreaticoduodenectomy ; Positron Emission Tomography Computed Tomography
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a case report.
Autorzy:
Chan W; Irvine Department of Radiological Sciences, University of California, 101 The City Drive South, Orange, CA, 92868, USA.
Park S; Irvine Department of Radiological Sciences, University of California, 101 The City Drive South, Orange, CA, 92868, USA.
Shirkhoda L; Irvine Department of Radiological Sciences, University of California, 101 The City Drive South, Orange, CA, 92868, USA.
O'Connell R; Irvine Department of Pathology and Laboratory Medicine, School of Medicine, University of California, University of California Irvine, Irvine, CA, 92697, USA.
Houshyar R; Irvine Department of Radiological Sciences, University of California, 101 The City Drive South, Orange, CA, 92868, USA. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Nov 16; Vol. 17 (1), pp. 477. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Carcinoma*/surgery
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/therapy
Pancreatic Neoplasms*/pathology
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/therapy
Adenocarcinoma*/pathology
Humans ; Male ; Middle Aged ; Osteoclasts/pathology ; Pancreas/pathology ; Giant Cells/pathology ; Disease Progression
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Enhancing Mural Nodules in the Main Pancreatic Duct of Main and Mixed Types of Intraductal Papillary Mucinous Neoplasms: Does Size Matter in Malignancy Risk?
Autorzy:
Chon HK; Department of Internal Medicine, Wonkwang University College of Medicine, Iksan, Korea.; Institution of Wonkwang Medical Science, Wonkwang University College of Medicine, Iksan, Korea.
Song TJ; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Yoo KH; Department of Internal Medicine, Wonkwang University College of Medicine, Iksan, Korea.
Hwang JS; Center of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Changwon Hanmaeum Hospital, Hanyang University College of Medicine, Changwon, Korea.
Kim MH; Center of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Changwon Hanmaeum Hospital, Hanyang University College of Medicine, Changwon, Korea.
Choi EK; Department of Internal Medicine, Jeju National University College of Medicine, Jeju, Korea.
Kim TH; Department of Internal Medicine, Wonkwang University College of Medicine, Iksan, Korea.; Institution of Wonkwang Medical Science, Wonkwang University College of Medicine, Iksan, Korea.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2023 Nov 15; Vol. 17 (6), pp. 942-948. Date of Electronic Publication: 2023 Jun 15.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Carcinoma, Pancreatic Ductal*/surgery
Carcinoma, Pancreatic Ductal*/pathology
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/surgery
Pancreatic Neoplasms*/pathology
Neoplasms, Cystic, Mucinous, and Serous*/pathology
Humans ; Retrospective Studies ; Pancreatic Ducts/diagnostic imaging ; Pancreatic Ducts/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
MiR-200b categorizes patients into pancreas cystic lesion subgroups with different malignant potential.
Autorzy:
Benke M; Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary.
Zeöld A; Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary.
Kittel Á; Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary.; HUN-REN Institute of Experimental Medicine, Budapest, Hungary.
Khamari D; Department of Genetics, Cell and Immunobiology, and HUN-REN-SU Translational Extracellular Vesicle Research Group, Semmelweis University, Budapest, Hungary.
Hritz I; Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary.
Horváth M; Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary.
Keczer B; Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary.
Borka K; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
Szücs Á; Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary. .
Wiener Z; Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 14; Vol. 13 (1), pp. 19820. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
MicroRNAs*/genetics
Pancreatic Cyst*/diagnosis
Pancreatic Cyst*/genetics
Pancreatic Cyst*/pathology
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/genetics
Humans ; Biomarkers ; Pancreas/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
Autorzy:
Dailey KM; Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE, United States of America.; Cell and Molecular Biology Program, North Dakota State University, Fargo, ND, United States of America.; Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States of America.
Small JM; Department of Pathology and Microbiology, Rocky Vista University, Parker, CO, United States of America.
Pullan JE; Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States of America.; Department of Physical Science, Southern Utah University, Cedar City, UT, United States of America.
Winfree S; Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE, United States of America.; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States of America.
Vance KE; Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE, United States of America.
Orr M; Department of Statistics, North Dakota State University, Fargo, ND, United States of America.; Center for Diagnostics and Therapeutic Strategies in Pancreatic Cancer Biostatistics Core Facility, North Dakota State University, Fargo, ND, United States of America.
Mallik S; Cell and Molecular Biology Program, North Dakota State University, Fargo, ND, United States of America.; Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States of America.
Bayles KW; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States of America.
Hollingsworth MA; Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE, United States of America.
Brooks AE; Cell and Molecular Biology Program, North Dakota State University, Fargo, ND, United States of America.; Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States of America.; Department of Research and Scholarly Activity, Rocky Vista University, Ivins, UT, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 14; Vol. 18 (11), pp. e0289183. Date of Electronic Publication: 2023 Nov 14 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/therapy
Clostridium botulinum*
Humans ; Spores, Bacterial/genetics ; Clostridium/metabolism ; Oligopeptides/metabolism ; Tumor Microenvironment
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 39578

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies